Stanford scientists have invented a method that can determine the gestational age of a fetus by testing the mother's urine using metabolomics profiling and machine learning.
Stanford researchers have developed high-titer bacteriophage and annexin V formulations for rapid, more effective phage therapy against bacterial infection.
Researchers at Stanford and the Chan Zuckerberg Biohub have developed a transcriptomic characterization of human endometrium and identified specific gene signatures for use in evaluating endometrial samples for one or more menstrual cycle events.
Proliferative vitreoretinopathy (PVR) is a rare ocular condition that can lead to vision loss or blindness and is a complication of rhegmatogenous retinal detachment, severe diabetic retinopathy, and other conditions.
Researchers at Stanford University have developed a clinical transrectal imaging system for detection of prostate cancer using dual ultrasound and real-time photoacoustic imaging.
Researchers at Stanford are developing a device that uses quantum engineered states and interactions to detect electromagnetic waves with a sensitivity and bandwidth beyond that possible with existing technology.
Physicians at Stanford Lucile Packard Children's Hospital (LPCH) have developed a novel Vesico-Amniotic Shunt (VAS) for treatment of Prenatal Lower Urinary Tract Obstruction (LUTO).
Cancer specific antigenic epitopes called neoantigens are necessary for effective adoptive T cell therapies. Neoantigens generate cytotoxic T lymphocytes (CTLs) and CTLs can be exploited to safely target and eliminate cancerous cells.
Stanford researchers have developed a method to use conditional generative adversarial networks (C-GANs) for solving highly complex optimization problems, e.g., with 1050 to 10 80 dimensions.